1. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. (1st June 2020) Authors: Ding, Chenyu; Yi, Xuehan; Wu, Xiyue; Bu, Xingyao; Wang, Desheng; Wu, Zanyi; Zhang, Gaoqi; Gu, Jianjun; Kang, Dezhi Journal: Cancer letters Issue: Volume 479(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Granulocyte-macrophage colony-stimulating factor enhances effect of temozolomide on high-grade glioma cells. Issue 9 (October 2020) Authors: Yang, Dongyi; Cheng, Xue; Bu, Xingyao; Yan, Zhaoyue; Wu, Tao; Zhang, Yunke Journal: Anti-cancer drugs Issue: Volume 31:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. (18th May 2022) Authors: Yan, Zhaoyue; Gao, Yushuai; Yu, Jinliang; Shen, Zhiyuan; Bu, Xingyao Other Names: Passero Luiz Felipe Academic Editor. Journal: Journal of immunology research Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence. Issue 11 (4th November 2021) Authors: Sheng, Zhiyuan; Yu, Jinliang; Deng, Kaiyuan; Bu, Yage; Wu, Shuang; Xu, Sensen; Gao, Yushuai; Zhang, Qianqian; Yan, Zhaoyue; Bu, Chaojie; Chen, Zhongcan; Gu, Jianjun; Jia, Yan; Gao, Xinya; Zemmar, Ajmal; Sumardi, Fitri; Hernesniemi, Juha; Kong, Lingfei; Liu, Gang; Li, Ming Journal: Clinical and translational medicine Issue: Volume 11:Issue 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment. Issue 7 (8th July 2022) Authors: Xu, Sensen; Sheng, Zhiyuan; Yu, Jinliang; Deng, Kaiyuan; Wu, Shuang; Bu, Yage; Guo, Guangzhong; Zhang, Ziyue; Liu, Guanzheng; Gao, Yushuai; Yan, Zhaoyue; Bu, Chaojie; He, Yingkun; Liu, Gang; Zemmar, Ajmal; Hernesniemi, Juha; Kong, Lingfei; Wang, Meiyun; Li, Tianxiao; Bu, Xingyao Journal: Clinical and translational medicine Issue: Volume 12:Issue 7(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RETRACTED: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. (1st June 2020) Authors: Ding, Chenyu; Yi, Xuehan; Wu, Xiyue; Bu, Xingyao; Wang, Desheng; Wu, Zanyi; Zhang, Gaoqi; Gu, Jianjun; Dezhi Kang, Journal: Cancer letters Issue: Volume 479(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Retraction notice to "Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma" [Cancer Lett. 479 (2020) 1–12]. (1st May 2022) Authors: Ding, Chenyu; Yi, Xuehan; Wu, Xiyue; Bu, Xingyao; Wang, Desheng; Wu, Zanyi; Zhang, Gaoqi; Gu, Jianjun; Kang, Dezhi Journal: Cancer letters Issue: Volume 533(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗